279 related articles for article (PubMed ID: 23754771)
21. A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials.
Coates M; Spanos M; Parmar P; Chandrasekhar T; Sikich L
Drug Saf; 2018 May; 41(5):465-471. PubMed ID: 29318515
[TBL] [Abstract][Full Text] [Related]
22. Reporting of fatal adverse drug reactions.
Liu BA; Knowles SR; Mittmann N; Einarson T; Shear NH
Can J Clin Pharmacol; 2001; 8(2):84-8. PubMed ID: 11493936
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
24. Adverse Effects of Psychotropic Medications: A Call to Action.
Mago R
Psychiatr Clin North Am; 2016 Sep; 39(3):361-73. PubMed ID: 27514294
[TBL] [Abstract][Full Text] [Related]
25. Review of safety assessment methods used in pediatric psychopharmacology.
Greenhill LL; Vitiello B; Riddle MA; Fisher P; Shockey E; March JS; Levine J; Fried J; Abikoff H; Zito JM; McCracken JT; Findling RL; Robinson J; Cooper TB; Davies M; Varipatis E; Labellarte MJ; Scahill L; Walkup JT; Capasso L; Rosengarten J
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):627-33. PubMed ID: 12921469
[TBL] [Abstract][Full Text] [Related]
26. Adverse psychic reactions to psychotropic drugs--a report from the AMUP study.
Grohmann R; Ströbel C; Rüther E; Dirschedl P; Helmchen H; Hippius H; Müller-Oerlinghausen B; Schmidt LG; Wolf B
Pharmacopsychiatry; 1993 May; 26(3):84-93. PubMed ID: 8415899
[TBL] [Abstract][Full Text] [Related]
27. Guidelines for submitting adverse event reports for publication.
Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards IR; Fernandez AM; Freedman SB; Goldsmith DI; Huang K; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ;
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):581-7. PubMed ID: 17471601
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.
Liang R; Borgundvaag B; McIntyre M; Thwaites C; Ragan K; Wyllie A
Pharmacotherapy; 2014 Nov; 34(11):1159-66. PubMed ID: 25266970
[TBL] [Abstract][Full Text] [Related]
29. [Principle of adverse drug reaction causality judgement and interpretation of causality assessment method both in China and abroad].
Wei X; Xie YM
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2744-7. PubMed ID: 23285925
[TBL] [Abstract][Full Text] [Related]
30. Contribution of pharmacists to the reporting of adverse drug reactions.
van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
[TBL] [Abstract][Full Text] [Related]
31. Effect of reporting bias in the analysis of spontaneous reporting data.
Ghosh P; Dewanji A
Pharm Stat; 2015; 14(1):20-5. PubMed ID: 25376637
[TBL] [Abstract][Full Text] [Related]
32. [Characterization of adverse drug reactions in adults over 44 years of age in Bogota, January-December, 2012].
Chaves M
Biomedica; 2015; 35(1):34-42. PubMed ID: 26148032
[TBL] [Abstract][Full Text] [Related]
33. [Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system].
Aguirre C; García M
Med Clin (Barc); 2016 Nov; 147(10):461-464. PubMed ID: 27450163
[No Abstract] [Full Text] [Related]
34. Cardiac adverse effects associated with psychotropic drugs.
Schmid C; Grohmann R; Engel RR; Rüther E; Kropp S
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S65-9. PubMed ID: 15052516
[TBL] [Abstract][Full Text] [Related]
35. [Analyze causes of adverse reactions induced by traditional Chinese medicine injections from its quality standards].
Cui HY; Liang AH
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):934-40. PubMed ID: 25204194
[TBL] [Abstract][Full Text] [Related]
36. Interrater reliability of the modified Monitoring of Side Effects Scale for assessment of adverse effects of psychiatric medication in clinical and research settings.
Nugent KL; Spahr E; Toroney J; Mojtabai R; Nettles C; Turner LW; Fenton A; Spivak A; Cullen BA; Everett A; Eaton WW
J Clin Psychopharmacol; 2015 Jun; 35(3):324-8. PubMed ID: 25928700
[TBL] [Abstract][Full Text] [Related]
37. Quality of Evidence Supporting Major Psychotropic Drug-Drug Interaction Warnings: A Systematic Literature Review.
Nguyen T; Liu X; Abuhashem W; Bussing R; Winterstein AG
Pharmacotherapy; 2020 May; 40(5):455-468. PubMed ID: 32107798
[TBL] [Abstract][Full Text] [Related]
38. Age-grouped differences in adverse drug events from psychotropic medication.
Safer DJ
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):299-309. PubMed ID: 21851188
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular side effects of psychopharmacologic therapy.
Potočnjak I; Degoricija V; Vukičević Baudoin D; Čulig J; Jakovljević M
Int J Cardiol; 2016 Sep; 219():367-72. PubMed ID: 27352209
[TBL] [Abstract][Full Text] [Related]
40. [Importance of drug surveillance in psychiatry--the AMSP project].
Zullino D; Baumann P; Grohmann R; Greil W
Rev Med Suisse Romande; 2000 Feb; 120(2):105-9. PubMed ID: 10748695
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
